Gensaic to collaborate exclusively with Ovid Therapeutics to develop up to three genetic medicines for CNS indications using its proprietary phage-derived particle (PDP) platform; terms are currently ...

Phage display research is advancing rapidly. Creative Biolabs supports this momentum with cutting‑edge platforms designed to address emerging challenges in binder discovery and screening.

Bacteriophages, the most abundant biological entities on Earth, are increasingly recognized not only for their roles in bacterial infection biology and therapeutic development but also as ...

Aims: Novel anticancer strategies have employed bacteriophages as drug carriers and display platforms for anticancer agents; however, bacteriophage-based platforms maintain their natural antibacterial ...